查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1594912

病人血液管理的全球市場

Patient Blood Management
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 93 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球患者血液管理市場預計將達到 236 億美元

全球患者血液管理市場預計 2023 年為 152 億美元，預計到 2030 年將達到 236 億美元，2023 年至 2030 年複合年成長率為 6.4%。 「設備」是本報告分析的細分市場之一，預計複合年成長率為 6.5%，到分析期結束時將達到 101 億美元。分析期內試劑和套件產業的複合年成長率預計為 7.1%。

美國市場估計達40億美元，中國預計複合年成長率為9.8%

到 2023 年，美國患者血液管理市場預計將達到 40 億美元。中國作為世界第二大經濟體，預計2030年市場規模將達到56億美元，2023年至2030年的分析期間複合年成長率為9.8%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 3.3% 和 5.8%。在歐洲，德國的複合年成長率預計為 3.7%。

全球患者血液管理市場－主要趨勢與促進因素總結

為什麼患者血液管理在現代醫療保健中至關重要？

患者血液管理 (PBM) 提供了一種系統方法來最佳化可能需要輸血的患者的護理，並已成為現代醫療保健的關鍵要素。 PBM 的重點是透過管理貧血、減少術中失血和最佳化患者的紅血球量來最大程度地減少輸血需求並改善臨床結果。 PBM 的重要性在於它能夠透過降低與輸血相關的風險（例如感染疾病、免疫反應和輸血相關併發症）來提高病患安全。這種以證據為基礎的方法對於手術、創傷和慢性貧血的患者尤其重要，因為它減少了對血液製品的依賴並導致更快的康復。

透過最大程度地減少不必要的輸血，PBM 在保存血液供應方面也發揮著重要作用，而血液供應通常有限。這種方法對於醫療保健系統至關重要，特別是在血液稀缺時期和血液製品取得機會有限的地區。由於人口老化和外科手術的增加，對血液的需求不斷增加，PBM 促進了血液的有效利用，同時確保將血液輸送給最需要的患者。這種做法不僅節省資源，還降低了與輸血相關的醫療成本，使得 PBM 對於永續醫療管理至關重要。

此外，PBM 透過採取主動、個人化的方法來管理每位患者的血液需求，從而促進整體結果的改善。透過補充鐵質、紅血球生成刺激因子製劑和先進手術技術等干涉措施，PBM 在手術或治療前為患者做好充分準備。這種綜合方法可以減少併發症的可能性、縮短住院時間並延長復原時間。隨著醫療保健越來越強調以患者為中心的護理，PBM 提供符合現代醫療保健提供原則的客製化預防策略，提高患者滿意度和健康結果。

科技進步如何增強病患血液管理？

技術進步透過引入最佳化血液使用、最大限度減少失血並改善患者治療效果的新工具和方法，大大改善了患者的血液管理。 PBM 的主要創新之一是開發先進的診斷工具，能夠在手術或治療前及早發現和管理貧血。照護端 (POC) 測試和自動血液分析儀等技術可以快速評估血紅蛋白和缺鐵情況，使醫療保健提供者能夠更早診斷和治療貧血。準確、即時的診斷使臨床醫生能夠主動實施個人化策略，以最佳化血紅蛋白水平並減少需要輸血的可能性。這些技術支持預防性貧血管理（PBM 的核心要素），確保患者在接受手術前處於最佳狀態。

PBM 的另一個重大進展是使用細胞回收和保血手術技術，最大限度地減少術中失血並減少輸血需求。術中細胞回收裝置可以在手術期間收集、處理患者的血液並將其重新輸入患者體內，從而減少對供血的依賴。此外，切口更小、失血更少的微創或腹腔鏡手術也越來越受歡迎。這些手術對於涉及大量失血的手術特別有益，例如整形外科手術或心血管手術。透過結合細胞回收和微創技術，PBM 減少了對外部血液的需求，改善了手術結果並支持資源效率。

紅血球生成促效劑 (ESA) 和鐵補充品等藥物創新在 PBM 中也發揮著重要作用，它們可以促進紅血球生成並在無需輸血的情況下解決貧血問題。 ESA 刺激骨髓產生更多紅血球，因此對於慢性貧血或接受化療的患者特別有益。鐵補充品，無論是口服還是靜脈注射，都有助於最佳化血紅蛋白，並為可能涉及出血的手術做好準備。為了促進患者健康，同時最大限度地減少輸血需求，PBM 透過這些藥物干預措施為貧血管理提供非輸血選擇。這些治療方法使臨床醫生能夠根據每位患者的需求量身定做 PBM 策略，並提供更有效、侵入性更小的血液管理方法。

患者血液管理如何使患者和醫療保健提供者受益？

患者血液管理為患者和醫療保健提供者提供了顯著的好處，改善了患者的治療結果，降低了醫療成本，並最佳化了有限血液資源的使用。對於患者而言，PBM 透過最大限度地減少感染疾病、輸血反應和免疫併發症等輸血相關風險來提高安全性。透過採用輸血以外的干涉措施，例如貧血管理、手術保存技術和使用患者自己的血液，PBM 可以降低副作用的可能性並促進更安全的醫療保健。對於接受大型手術的患者，PBM 可以保證精心管理的血液策略，優先考慮患者健康並減少輸血需求，從而縮短康復時間並縮短住院時間。

對於醫療保健提供者而言，PBM 透過減少對供應量通常有限的捐血者的依賴來支持高效和永續的資源管理。由於捐血率無法跟上不斷成長的需求，PBM 可以幫助為有緊急需求的患者（例如創傷或嚴重出血病例）保留血液資源。透過最佳化護理和非輸血干預措施來減少血液使用，醫療保健提供者可以更有效地管理資源，降低血液短缺的風險，並確保在真正需要時提供血液製品。 PBM 也降低了與輸血相關的成本，例如儲存、篩檢和管理成本。這種成本效率對於大型醫院和衛生系統尤其有價值，因為有效管理血液資源可以節省大量資金。

改善患者治療效果和護理品質是 PBM 的其他好處，促進更以患者為中心和個人化的醫療保健方法。透過早期發現貧血、保血外科手術、非輸血選擇等，PBM 使醫療保健提供者能夠根據每位患者的需求制定個人化的護理計劃。這種客製化方法可降低併發症的可能性，支持更快的康復，並提高患者滿意度和整體護理品質。透過主動管理患者的血液健康，PBM 最大限度地減少住院和再入院次數，並創造更簡化的醫療保健體驗。這些好處共同改善了醫療保健服務的臨床和營運方面，並支持高品質、具有成本效益、以患者為中心的護理目標。

是什麼推動了患者血液管理市場的成長？

患者血液管理市場的成長是由輸血相關風險意識的提高、手術和慢性病病例數量的增加、診斷和治療技術的進步以及促進 PBM 採用的支持性監管政策推動的。人們對輸血相關風險和併發症的認知不斷提高，促使醫療保健提供者尋求比傳統輸血方法更安全、更有效的替代方法。對感染疾病、免疫反應和潛在併發症的擔憂凸顯了 PBM 計劃的必要性，以最大限度地減少輸血並提供更安全的護理選擇。這種臨床視角的轉變導致更多的醫院和醫療機構採用 PBM通訊協定，增加了對支持全面血液管理的技術和方法的需求。

手術數量的增加以及癌症、腎臟疾病和心血管疾病等慢性疾病盛行率的上升也推動了對 PBM 解決方案的需求。由於這些疾病通常需要手術干預和頻繁住院治療，因此醫療保健提供者需要有效的血液管理策略來支持患者護理，同時減少輸血依賴。 PBM通訊協定在高失血量手術中特別有用，因為它們可以在手術前和手術過程中最佳化患者的血液狀態，從而減少輸血的需要。隨著手術和住院數量的不斷增加，對有效的 PBM 解決方案的需求也在增加，以有效管理血液和改善患者的治療效果。

診斷和治療技術的進步為 PBM 市場的成長做出了重大貢獻，因為它們實現了更準確、更有效的個人化血液管理策略。新的診斷工具，例如現場檢測和嚴重貧血篩檢，可以對患者的血液水平進行早期療育和精確管理。包括細胞回收裝置和微創技術在內的外科創新可以減少手術過程中的失血量，並最大限度地減少對捐血的需求。紅血球生成刺激因子製劑和靜脈補充品等藥物進步為貧血患者提供了輸血以外的治療選擇。這些創新使 PBM 計劃變得更加容易獲得和有效，推動了世界各地醫院和醫療機構的採用。

隨著醫療機構和政府認知到 PBM 在提高病患安全和最佳化血液資源方面的價值，支持性監管政策和指南也正在推動 PBM 市場的成長。世界衛生組織 (WHO) 等監管機構和多個國家的衛生署正在鼓勵醫療保健提供者採用 PBM 作為其標準治療通訊協定的一部分。目前，許多醫療保健系統要求醫院實施 PBM 策略，以符合品質標準、降低醫療成本並節省血液資源。此外，患者權益團體和醫療保健組織正在加強教育力度，以提高醫療保健專業人員和公眾對 PBM 益處的認知。隨著醫療保健提供者遵循最佳實踐和合規標準，這些監管和宣傳工作正在擴大 PBM 的採用並推動市場的顯著成長。

這些因素的結合，包括對輸血風險的認知、外科手術和慢性病的增加、技術進步和支持性法律規範，正在推動患者血液管理市場的強勁成長。隨著醫療保健系統努力提供更安全、更具成本效益和更節約資源的護理，PBM 正在成為現代以病人為中心的護理服務的基石。

部分

產品（設備、試劑及套件、軟體、配件）；組件（全血及紅血球、血漿）；最終用途（血庫、醫院）；

調查企業舉例（共42家）

  • Abbott Laboratories
  • Asahi Kasei Medical Co. Ltd.
  • B. Braun Melsungen AG
  • Biomerieux SA
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche LTD.
  • Fresenius Se & Co. KGaA
  • Grifols, SA
  • Haemonetics Corporation
  • Immucor, Inc.
  • Kaneka Corporation
  • Livanova PLC
  • Macopharma
  • Terumo Corporation

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP22467

Global Patient Blood Management Market to Reach US$23.6 Billion by 2030

The global market for Patient Blood Management estimated at US$15.2 Billion in the year 2023, is expected to reach US$23.6 Billion by 2030, growing at a CAGR of 6.4% over the analysis period 2023-2030. Instruments, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$10.1 Billion by the end of the analysis period. Growth in the Reagents & Kits segment is estimated at 7.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.0 Billion While China is Forecast to Grow at 9.8% CAGR

The Patient Blood Management market in the U.S. is estimated at US$4.0 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$5.6 Billion by the year 2030 trailing a CAGR of 9.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 5.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Global Patient Blood Management Market - Key Trends & Drivers Summarized

Why Is Patient Blood Management Essential in Modern Healthcare?

Patient Blood Management (PBM) has become a crucial component in modern healthcare, providing a systematic approach to optimize the care of patients who might need blood transfusions. PBM focuses on minimizing the need for blood transfusions by managing anemia, reducing blood loss during surgery, and optimizing patients' red blood cell mass, thereby improving clinical outcomes. The importance of PBM lies in its ability to enhance patient safety by reducing the risks associated with transfusions, such as infections, immune reactions, and transfusion-related complications. This evidence-based approach is especially important for patients undergoing surgeries, trauma cases, or those with chronic anemia, as it reduces dependency on blood products and leads to faster recovery.

By minimizing unnecessary transfusions, PBM also plays a significant role in conserving blood supplies, which are often in limited availability. This approach is vital for healthcare systems, particularly in times of blood shortages or in regions with limited access to blood products. With the rising demand for blood due to aging populations and increasing surgical procedures, PBM ensures that blood is available for patients who need it most while encouraging efficient blood use. This practice not only conserves resources but also lowers healthcare costs associated with blood transfusions, making PBM essential for sustainable healthcare management.

Moreover, PBM promotes better overall outcomes by taking a preventive, individualized approach to managing each patient's blood needs. Through interventions like iron supplementation, erythropoiesis-stimulating agents, and advanced surgical techniques, PBM prepares patients adequately before surgery or treatment. This comprehensive approach reduces the likelihood of complications, shortens hospital stays, and enhances recovery times. As healthcare increasingly emphasizes patient-centered care, PBM provides a tailored, preventive strategy that aligns with modern principles of healthcare delivery, improving both patient satisfaction and health outcomes.

How Are Technological Advancements Enhancing Patient Blood Management?

Technological advancements are significantly enhancing Patient Blood Management by introducing new tools and methods that optimize blood use, minimize blood loss, and improve patient outcomes. One key innovation in PBM is the development of advanced diagnostic tools that allow for early detection and management of anemia before surgery or treatment. Technologies like point-of-care (POC) testing and automated blood analyzers enable rapid hemoglobin assessments and iron deficiency evaluations, allowing healthcare providers to diagnose and treat anemia early. With accurate, real-time diagnostics, clinicians can implement personalized strategies to optimize hemoglobin levels in advance, reducing the likelihood of needing transfusions. These technologies support proactive anemia management, a core component of PBM, ensuring that patients are in the best possible condition before undergoing procedures.

Another major advancement in PBM is the use of cell salvage and blood-sparing surgical techniques, which minimize blood loss and reduce transfusion needs during surgery. Intraoperative cell salvage devices collect and process a patient’s blood during surgery, allowing it to be reinfused back into the patient, thus reducing dependency on donor blood. Additionally, minimally invasive and laparoscopic surgical techniques are becoming increasingly common, as they involve smaller incisions, leading to less blood loss. These techniques are particularly beneficial in high-blood-loss surgeries, such as orthopedic and cardiac procedures. By incorporating cell salvage and minimally invasive techniques, PBM reduces the need for external blood, improving surgical outcomes and supporting resource efficiency.

Pharmaceutical innovations, such as erythropoiesis-stimulating agents (ESAs) and iron supplements, are also playing a critical role in PBM by boosting red blood cell production and addressing anemia without the need for transfusions. ESAs stimulate the bone marrow to produce more red blood cells, which is especially beneficial for patients with chronic anemia or those undergoing chemotherapy. Iron supplements, whether oral or intravenous, support hemoglobin optimization, preparing patients for procedures that may involve blood loss. With these pharmaceutical interventions, PBM offers non-transfusion options for managing anemia, aligning with its goal to enhance patient health while minimizing transfusion requirements. These therapies empower clinicians to tailor PBM strategies to each patient’s needs, providing a more effective and less invasive approach to blood management.

What Are the Benefits of Patient Blood Management for Patients and Healthcare Providers?

Patient Blood Management provides significant benefits for both patients and healthcare providers, improving patient outcomes, reducing healthcare costs, and optimizing the use of limited blood supplies. For patients, PBM enhances safety by minimizing the risks associated with blood transfusions, such as infections, transfusion reactions, and immunologic complications. By employing non-transfusion interventions like anemia management, surgical blood-sparing techniques, and the use of patient’s own blood, PBM reduces the potential for adverse reactions and promotes a safer healthcare experience. For patients undergoing major surgeries, PBM offers the assurance of a carefully managed blood strategy that prioritizes their health, reduces the need for transfusions, and leads to quicker recovery times and shorter hospital stays.

For healthcare providers, PBM supports efficient and sustainable resource management by reducing reliance on donor blood, which is often in limited supply. With blood donation rates unable to keep pace with increasing demand, PBM helps preserve blood resources for patients with critical needs, such as trauma or severe bleeding cases. By reducing blood usage through optimized care and non-transfusion interventions, healthcare providers can manage resources more effectively, lowering the risk of blood shortages and ensuring that blood products are available when truly necessary. PBM also decreases costs associated with blood transfusions, including storage, screening, and administration expenses. This cost-efficiency is especially valuable in large hospitals and health systems, where managing blood resources effectively can lead to substantial financial savings.

Enhanced patient outcomes and quality of care are additional benefits of PBM, as it fosters a more patient-centered, individualized approach to healthcare. Through early anemia detection, blood-sparing surgical practices, and non-transfusion options, PBM enables healthcare providers to create personalized care plans tailored to each patient’s needs. This customized approach reduces the likelihood of complications and supports faster recoveries, improving patient satisfaction and overall quality of care. By proactively managing patients’ blood health, PBM minimizes hospital stays and readmissions, leading to a more streamlined healthcare experience. Together, these benefits improve both the clinical and operational aspects of healthcare delivery, supporting the goal of high-quality, cost-effective, and patient-centered care.

What Is Fueling the Growth in the Patient Blood Management Market?

The growth in the Patient Blood Management market is driven by the rising awareness of transfusion-related risks, increasing surgical and chronic disease cases, advancements in diagnostic and therapeutic technologies, and supportive regulatory policies promoting PBM adoption. As awareness grows around the risks and complications associated with blood transfusions, healthcare providers are increasingly seeking safer and more effective alternatives to traditional transfusion practices. Concerns over infections, immunologic reactions, and potential complications have highlighted the need for PBM programs that minimize transfusions and provide safer care options. This shift in clinical perspective has encouraged more hospitals and healthcare facilities to adopt PBM protocols, driving demand for technologies and practices that support comprehensive blood management.

Increasing numbers of surgeries and the rising prevalence of chronic diseases, such as cancer, kidney disease, and cardiovascular conditions, are also fueling the demand for PBM solutions. With these conditions often requiring surgical interventions or frequent hospitalizations, healthcare providers need effective blood management strategies to support patient care while reducing transfusion dependency. PBM protocols are particularly valuable in high-blood-loss surgeries, as they optimize patient blood health before and during procedures, decreasing the need for transfusions. As the volume of surgeries and hospitalizations continues to grow, so does the demand for effective PBM solutions to manage blood efficiently and improve patient outcomes.

Advancements in diagnostic and therapeutic technologies are significantly contributing to PBM market growth, as they enable more precise, effective, and personalized blood management strategies. New diagnostic tools, such as point-of-care testing and advanced anemia screening, allow for early intervention and accurate management of patient blood levels. Surgical innovations, including cell salvage devices and minimally invasive techniques, reduce blood loss during procedures, minimizing the need for donor blood. Pharmaceutical advancements, such as erythropoiesis-stimulating agents and intravenous iron supplements, provide non-transfusion treatment options for patients with anemia. These technological innovations make PBM programs more accessible and effective, supporting their adoption in hospitals and healthcare facilities worldwide.

Supportive regulatory policies and guidelines are also driving growth in the PBM market, as healthcare organizations and governments recognize the value of PBM in improving patient safety and optimizing blood resources. Regulatory bodies like the World Health Organization (WHO) and health ministries in several countries are encouraging healthcare providers to adopt PBM practices as part of their standard care protocols. Many healthcare systems now require hospitals to implement PBM strategies to comply with quality standards, reduce healthcare costs, and conserve blood resources. Additionally, patient advocacy groups and health organizations have increased educational efforts to promote awareness of PBM benefits among healthcare professionals and the public. These regulatory and advocacy efforts are expanding the adoption of PBM, driving significant growth in the market as providers align with best practices and compliance standards.

Together, these factors—awareness of transfusion risks, increasing surgical and chronic disease prevalence, technological advancements, and supportive regulatory frameworks—are driving robust growth in the Patient Blood Management market. As healthcare systems aim to provide safer, more cost-effective, and resource-efficient care, PBM is becoming a cornerstone of modern, patient-centered healthcare delivery.

SCOPE OF STUDY:

The report analyzes the Patient Blood Management market in terms of US$ Million by the following Component; End-Use; Product, and Geographic Regions/Countries:

Segments:

Product (Instruments, Reagents & Kits, Software, Accessories); Component (Whole Blood & Red Blood Cells, Plasma); End-Use (Blood Banks, Hospitals)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Abbott Laboratories
  • Asahi Kasei Medical Co. Ltd.
  • B. Braun Melsungen AG
  • Biomerieux SA
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche LTD.
  • Fresenius Se & Co. KGaA
  • Grifols, S.A.
  • Haemonetics Corporation
  • Immucor, Inc.
  • Kaneka Corporation
  • Livanova PLC
  • Macopharma
  • Terumo Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Patient Blood Management - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Focus on Blood Conservation Drives Demand for Patient Blood Management (PBM) Solutions
    • Rising Incidence of Chronic Diseases Expands Addressable Market for PBM
    • Advancements in Blood Transfusion Technologies Propel Market Growth
    • Growing Use of Point-of-Care Hemoglobin Testing Drives PBM Solutions
    • Patient Blood Management Crucial for Enhancing Surgical Outcomes
    • Use of AI for Blood Utilization Optimization Sets the Stage for PBM Growth
    • Increasing Demand for Bloodless Surgery Expands PBM Applications
    • Innovations in Anemia Management Propel PBM Market Expansion
    • Focus on Reducing Blood Transfusion-Related Risks Drives PBM Adoption
    • Use of PBM in Oncology Care Expands Market Opportunities
    • Growing Adoption in Emergency and Trauma Care Expands PBM Applications
    • Use of PBM in Geriatric Care Strengthens Market Opportunities
    • Strategic Investments in Automated Blood Management Solutions Propel PBM Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Patient Blood Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Patient Blood Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Patient Blood Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Reagents & Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Accessories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Whole Blood & Red Blood Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Whole Blood & Red Blood Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Whole Blood & Red Blood Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Plasma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Plasma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Plasma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Blood Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Blood Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Blood Banks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 28: World Patient Blood Management Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • JAPAN
    • Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • CHINA
    • Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • EUROPE
    • Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Patient Blood Management by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Patient Blood Management by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Patient Blood Management by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • FRANCE
    • Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: France 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: France 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • GERMANY
    • Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Germany 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Italy 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: UK 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Spain 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Spain 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Spain 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Russia 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Russia 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Russia 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Patient Blood Management by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Patient Blood Management by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Patient Blood Management by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Australia 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Australia 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Australia 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • INDIA
    • Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 161: India Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: India 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: India 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: India 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: South Korea 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: South Korea 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: South Korea 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Patient Blood Management by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Patient Blood Management by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Latin America 16-Year Perspective for Patient Blood Management by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Latin America 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Latin America 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Argentina 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Argentina 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Argentina 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Brazil 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Brazil 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 217: Brazil 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 220: Mexico 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 223: Mexico 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 226: Mexico 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 229: Rest of Latin America 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 232: Rest of Latin America 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 235: Rest of Latin America 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Patient Blood Management by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Patient Blood Management by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 238: Middle East 16-Year Perspective for Patient Blood Management by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 241: Middle East 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 244: Middle East 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 250: Iran 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 253: Iran 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 256: Iran 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 259: Israel 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 262: Israel 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 265: Israel 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 268: Saudi Arabia 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 271: Saudi Arabia 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 274: Saudi Arabia 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 277: UAE 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 280: UAE 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 283: UAE 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 286: Rest of Middle East 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 289: Rest of Middle East 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 292: Rest of Middle East 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
  • AFRICA
    • Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 295: Africa 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 298: Africa 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 301: Africa 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030

IV. COMPETITION